Hepatocellular adenoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatocellular adenoma}} | {{Hepatocellular adenoma}} | ||
{{CMG}}; {{AE}} {{NM}} | |||
==Overview== | |||
==Hepatocellular adenoma medical therapy== | |||
The predominant therapy for hepatocellular adenoma is surgical resection to prevent bleeding and malignant transformation. Close monitoring and imaging is required.<ref name="pmid18333188">{{cite journal| author=Barthelmes L, Tait IS| title=Liver cell adenoma and liver cell adenomatosis. | journal=HPB (Oxford) | year= 2005 | volume= 7 | issue= 3 | pages= 186-96 | pmid=18333188 | doi=10.1080/13651820510028954 | pmc=PMC2023950 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18333188 }} </ref> | |||
==References== | ==References== | ||
{{reflist| | {{reflist|1}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 14:40, 14 October 2015
|
Hepatocellular adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatocellular adenoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Hepatocellular adenoma medical therapy |
|
Risk calculators and risk factors for Hepatocellular adenoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Hepatocellular adenoma medical therapy
The predominant therapy for hepatocellular adenoma is surgical resection to prevent bleeding and malignant transformation. Close monitoring and imaging is required.[1]
References
- ↑ Barthelmes L, Tait IS (2005). "Liver cell adenoma and liver cell adenomatosis". HPB (Oxford). 7 (3): 186–96. doi:10.1080/13651820510028954. PMC 2023950. PMID 18333188.